These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37463395)

  • 1. Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update: ASCO Guideline Q and A.
    Virgo KS; Rumble RB; Talcott JA
    JCO Oncol Pract; 2023 Oct; 19(10):843-846. PubMed ID: 37463395
    [No Abstract]   [Full Text] [Related]  

  • 2. Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update.
    Virgo KS; Rumble RB; de Wit R; Mendelson DS; Smith TJ; Taplin ME; Wade JL; Bennett CL; Scher HI; Nguyen PL; Gleave M; Morgan SC; Loblaw A; Sachdev S; Graham DL; Vapiwala N; Sion AM; Simons VH; Talcott J
    J Clin Oncol; 2021 Apr; 39(11):1274-1305. PubMed ID: 33497248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update.
    Virgo KS; Rumble RB; Talcott J
    J Clin Oncol; 2023 Jul; 41(20):3652-3656. PubMed ID: 37011338
    [No Abstract]   [Full Text] [Related]  

  • 4. Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement.
    Chen RC; Rumble RB; Loblaw DA; Finelli A; Ehdaie B; Cooperberg MR; Morgan SC; Tyldesley S; Haluschak JJ; Tan W; Justman S; Jain S
    J Clin Oncol; 2016 Jun; 34(18):2182-90. PubMed ID: 26884580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone Health and Bone-Targeted Therapies for Prostate Cancer: ASCO Endorsement of a Cancer Care Ontario Guideline.
    Saylor PJ; Rumble RB; Tagawa S; Eastham JA; Finelli A; Reddy PS; Kungel TM; Nissenberg MG; Michalski JM
    J Clin Oncol; 2020 May; 38(15):1736-1743. PubMed ID: 31990618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American Society of Clinical Oncology endorsement of the Cancer Care Ontario Practice Guideline on nonhormonal therapy for men with metastatic hormone-refractory (castration-resistant) prostate cancer.
    Basch EM; Somerfield MR; Beer TM; Carducci MA; Higano CS; Hussain MH; Scher HI;
    J Clin Oncol; 2007 Nov; 25(33):5313-8. PubMed ID: 17925542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline.
    Loblaw DA; Virgo KS; Nam R; Somerfield MR; Ben-Josef E; Mendelson DS; Middleton R; Sharp SA; Smith TJ; Talcott J; Taplin M; Vogelzang NJ; Wade JL; Bennett CL; Scher HI;
    J Clin Oncol; 2007 Apr; 25(12):1596-605. PubMed ID: 17404365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an AUA/ASTRO/SUO Guideline Summary.
    Bekelman JE; Rumble RB; Freedland SJ
    J Oncol Pract; 2018 Oct; 14(10):618-624. PubMed ID: 30199312
    [No Abstract]   [Full Text] [Related]  

  • 9. Positron emission tomography for prostate, bladder, and renal cancer.
    Schöder H; Larson SM
    Semin Nucl Med; 2004 Oct; 34(4):274-92. PubMed ID: 15493005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline.
    Eggener SE; Rumble RB; Armstrong AJ; Morgan TM; Crispino T; Cornford P; van der Kwast T; Grignon DJ; Rai AJ; Agarwal N; Klein EA; Den RB; Beltran H
    J Clin Oncol; 2020 May; 38(13):1474-1494. PubMed ID: 31829902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2007 Update of ASCO Practice Guideline for the Initial Hormonal Management of Androgen-Sensitive Metastatic, Recurrent, or Progressive Prostate Cancer: Guideline Summary.
    J Oncol Pract; 2007 May; 3(3):175-177. PubMed ID: 29455596
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostate cancer survivorship care guideline: American Society of Clinical Oncology Clinical Practice Guideline endorsement.
    Resnick MJ; Lacchetti C; Bergman J; Hauke RJ; Hoffman KE; Kungel TM; Morgans AK; Penson DF
    J Clin Oncol; 2015 Mar; 33(9):1078-85. PubMed ID: 25667275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer.
    Cornford P; Bellmunt J; Bolla M; Briers E; De Santis M; Gross T; Henry AM; Joniau S; Lam TB; Mason MD; van der Poel HG; van der Kwast TH; Rouvière O; Wiegel T; Mottet N
    Eur Urol; 2017 Apr; 71(4):630-642. PubMed ID: 27591931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update of Guidelines for Management of Prostate Cancer in West Africa 2019: Consensus Working Document.
    Osaghae SO
    West Afr J Med; 2020; 37(2):159-172. PubMed ID: 32150635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement.
    Milowsky MI; Rumble RB; Booth CM; Gilligan T; Eapen LJ; Hauke RJ; Boumansour P; Lee CT
    J Clin Oncol; 2016 Jun; 34(16):1945-52. PubMed ID: 27001593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Update on current care guideline: prostate cancer].
    Duodecim; 2014; 130(16):1666-7. PubMed ID: 25269372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic Therapy Update on
    Garje R; Hope TA; Rumble RB; Parikh RA;
    JCO Oncol Pract; 2023 Mar; 19(3):132-135. PubMed ID: 36693228
    [No Abstract]   [Full Text] [Related]  

  • 18. Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource-Stratified Guideline Q and A.
    Al Sukhun S; Koczwara B; Temin S; Arun BK
    JCO Glob Oncol; 2024 Jan; 10():e2300411. PubMed ID: 38206289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic Therapy Update on
    Garje R; Rumble RB; Parikh RA
    J Clin Oncol; 2022 Nov; 40(31):3664-3666. PubMed ID: 36112960
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update.
    Kalemkerian GP; Narula N; Kennedy EB; Biermann WA; Donington J; Leighl NB; Lew M; Pantelas J; Ramalingam SS; Reck M; Saqi A; Simoff M; Singh N; Sundaram B
    J Clin Oncol; 2018 Mar; 36(9):911-919. PubMed ID: 29401004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.